SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-375203
Filing Date
2014-10-17
Accepted
2014-10-17 17:22:55
Documents
7
Effectiveness Date
2014-10-17

Document Format Files

Seq Description Document Type Size
1 DFAN14A d806344ddfan14a.htm DFAN14A 44595
2 GRAPHIC g8063441.jpg GRAPHIC 270007
3 GRAPHIC g8063442.jpg GRAPHIC 291173
4 GRAPHIC g8063443.jpg GRAPHIC 293766
5 GRAPHIC g8063444.jpg GRAPHIC 295141
6 GRAPHIC g8063445.jpg GRAPHIC 309421
7 GRAPHIC g806344g35s97.jpg GRAPHIC 289564
  Complete submission text file 0001193125-14-375203.txt   2456777
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-10269 | Film No.: 141162537
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A